Help us: Donate
Follow us on:
×

Menu

Back

Tag: NIA

SenNet
The National Institute of Health is going all-in on cellular senescence with its recently announced SenNet program. We asked two of the leading experts in aging research to weigh in on this initiative. The NIH takes notice  Cellular senescence has been at the forefront of longevity researchers' minds for quite some time now, as it...
Injection
The National Institutes of Aging in the United States, a component of the National Institutes of Health, is funding clinical trials for interventions that directly affect the root causes of age-related diseases. Direct funding for trials against aging Probably the most important and interesting part of this Funding Opportunity Announcement (FOA) is that the NIA...
Longevity Therapeutics banner
Like nearly all conferences this past year, the 3rd Annual Longevity Therapeutics Summit, presented by Hanson Wade Limited, went virtual this time around. This was a stark difference from the previous two, which were rather fancy affairs in downtown San Francisco. However, we were fortunate that the organizers went forward with the event, bringing together...
Ronald Kohanski Interview
It was a pleasure speaking to Dr. Ronald Kohanski at the 2019 Ending Age-Related Diseases conference. Dr. Kohanski joined the field of aging research in 2005 as a Program Officer for the Division of Aging Biology at the National Institute on Aging. He moved on to become its Deputy Director in 2007 and has held...